Biodyne Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	1,442	851.59	10.77
Depreciation & Amortization	1,241	1,328	1,622
Loss (Gain) From Sale of Assets	-16.2	-20.8	-55.75
Asset Writedown & Restructuring Costs	277	277	-
Loss (Gain) From Sale of Investments	-357.33	-354.05	-259.52
Other Operating Activities	121.76	269.42	-810.32
Change in Accounts Receivable	-1,734	-973.62	-198.16
Change in Inventory	-53.76	-78.93	68.22
Change in Accounts Payable	2.61	326.11	1.19
Change in Other Net Operating Assets	-991.72	-794.02	499.07
Operating Cash Flow	12.18	830.26	877.41
Operating Cash Flow Growth	-	-5.37%	-
Capital Expenditures	-3,311	-3,431	-539.15
Sale of Property, Plant & Equipment	172.86	172.86	208.06
Sale (Purchase) of Intangibles	-2,206	-2,206	-
Investment in Securities	12,835	12,880	-5,580
Other Investing Activities	-0	-0	-
Investing Cash Flow	7,491	7,416	-5,911
Long-Term Debt Repaid	-	-9.62	-10.51
Net Debt Issued (Repaid)	-9.44	-9.62	-10.51
Other Financing Activities	-	-	-193.35
Financing Cash Flow	-9.44	-9.62	-203.86
Foreign Exchange Rate Adjustments	250.71	-89.31	345
Net Cash Flow	7,744	8,147	-4,893
Free Cash Flow	-3,299	-2,601	338.26
Free Cash Flow Margin	-47.28%	-37.01%	6.42%
Free Cash Flow Per Share	-111.47	-88.24	-
Cash Interest Paid	0.16	0.16	0.17
Cash Income Tax Paid	-	8.86	-64.04
Levered Free Cash Flow	-	-5,250	-
Unlevered Free Cash Flow	-	-5,250	-
Change in Working Capital	-2,696	-1,520	370.33